1. Introduction {#s0005}
===============

An outbreak of unexplained pneumonia occurred in Wuhan City, Hubei Province, China, in December 2019 \[[@bb0005]\]. The virus causing the epidemic was detected as a new coronavirus (2019-nCoV), and the resulting pneumonia was then named by the WHO as Coronavirus Disease 2019 (COVID-19) \[[@bb0010], [@bb0015], [@bb0020]\]. As of March 17, 2020, a total of 81,118 patients in China have been diagnosed with confirmed COVID-19, and 68,802 patients were cured and discharged \[[@bb0025]\]. At the same time, the number of suspected cases has also decreased significantly. This shows that China\'s epidemic prevention policy has achieved initial results. However, the infection has spread to over 48 countries worldwide, especially in Iran, Korea and some European countries, even affecting the United States. The global risk of this epidemic was escalated to the highest level by the WHO on February 28. Fast and effective diagnostic methods for this disease are of great importance at present.

According to the latest Diagnosis and Treatment Program for COVID-19 of China \[[@bb0030]\], the diagnosis of COVID-19 requires a reverse-transcription polymerase chain reaction (RT-PCR) test, but a certain rate of false negative results has been reported \[[@bb0035]\]. Its limited production and relatively long testing period might not be conducive for screening. Accumulated clinical experience suggests that early chest computed tomography might be helpful in the differential diagnosis of suspected cases. Recently, Chung, Fang and Kanne, etc. reported the chest CT imaging features of COVID-19 \[[@bb0040], [@bb0045], [@bb0050]\]. Fang and Ai further studied the sensitivity of chest CT compared to RT-PCR with a relatively small sample \[[@bb0045],[@bb0055]\]. However, there is no agreed standard for how to confirm a diagnosis of COVID-19 with these features. We retrospectively collected chest CT images of suspected pneumonia patients, divided them according to the results of RT-PCR tests into positive and negative groups and then compared the differences in CT features between the two groups. Our goal is to use statistical methods to distinguish the imaging features of COVID-19 from other infectious pulmonary diseases and evaluate the diagnostic value of chest CT for suspected COVID-19 patients.

2. Materials and methods {#s0010}
========================

2.1. Patient population {#s0015}
-----------------------

The data used in this multicenter retrospective study were collected from three tertiary hospitals of two provinces in China. We enrolled a consecutive sample of suspected COVID-19 patients from January 12, 2020 to February 13, 2020 according to the following inclusion criteria: (1) suspicion of COVID-19 according to the 6th edition of the Diagnosis and Treatment Program for COVID-19 of China \[[@bb0030]\]; (2) age over 18 years; and (3) \<14 days from onset to first CT. Exclusion criteria included (1) past history of chronic lung disease and (2) pregnancy. Finally, 130 patients participated in our research. These patients\' general information, epidemiological history and CT imaging data were retrospectively collected.

2.2. Study design {#s0020}
-----------------

The diagnostic criteria for suspected cases are as defined in the 6th edition of the Diagnosis and Treatment Program for COVID-19 of China \[[@bb0030]\]. Nasopharyngeal swabs or sputum specimens were collected for running RT-PCR tests. Patients with first negative results received repeated tests after an interval of at least 1 day. All suspected cases were divided into positive and negative groups according to the results of the RT-PCR test. Patients who were negative before but positive on retests were eventually defined as positive.

All patients were prepared for CT scan examination; 33 patients were scanned on an Optima 670 CT scanner, GE, 41 patients were scanned on Revolution Frontier, GE, and 56 patients were scanned on a SOMATOM Definition Flash, Japan. Examinations followed the normal chest protocols. The overall scan time was 2 s, and the slice thickness for reconstruction was 1.25 mm. All the reports were issued after double-blind reviews by two radiologists and were resolved by a chief radiologist when opinions diverged.

This study was approved by the Ethics of Committees of the local hospital. Informed consent for this retrospective study was waived.

2.3. Qualitative image analysis {#s0025}
-------------------------------

According to the newly reported CT imaging features of COVID-19 and previous studies on the disease \[[@bb0060]\], we summarized the features that may appear on early chest CT. Lesion morphology was described as the presence of (1) a ground-glass opacities (GGOs); (2) consolidation; (3) crazy-paving pattern; (4) air bronchogram; (5) cavitation; (6) pulmonary nodule; (7) lymphadenopathy; (8) pleural effusion; (9) pulmonary atelectasis; or (10) pleural thickening. Lesion distribution, such as whether they were unilateral, bilateral or peripleural, the number of lung lobes involved and the involvement of the upper, middle, and lower fields of the lung were also counted.

2.4. Statistical analysis {#s0030}
-------------------------

Patient data were recorded by Epidata, and statistical analysis was performed using SPSS 13.0 (IBM Corporation). Normally distributed continuous variables are expressed as the mean ± SD ($\overline{x} \pm s$), and variables with a skewed distribution were presented as the medians (interquartile ranges). Independent *t*-tests were used to compare measurement data, and Mann-Whitney *U* tests were used for data with skewed distributions. Categorical information is described by percentages and was compared using the chi-squared test or Fisher\'s exact test. All statistical tests were bidirectional comparisons, and *P* \< .05 was regarded as statistically significant.

3. Results {#s0035}
==========

3.1. Comparisons of basic demographics {#s0040}
--------------------------------------

A total of 166 patients were enrolled in this study. Excluding 2 patients younger than 18 years old, 28 patients with normal CT presentations, 2 patients with underlying lung disease, 2 patients with onset to consultation over 14 days, and 2 patients who could not undergo chest CT because of pregnancy, 130 patients were finally included in the statistical analysis, with 54 testing positive and 76 testing negative for COVID-19 (see [Fig. 1](#f0005){ref-type="fig"} ). As shown in [Table 1](#t0005){ref-type="table"} , the mean age of the positive group patients was 45.1 ± 13.4 years, ranging from 19 to 77 years, and 28 of the patients were males (51.9%). The average time from symptom onset to the first visit was 4 days. For the negative group patients, the average age was 41.8 ± 13.6 years, ranging from 19 to 81 years, and 49 of the patients were males (64.5%). The average time from the onset of symptoms to the first visit was 3 days. The proportion of patients with a history of Wuhan residence and the clustering incidence between the two groups were statistically significant (*P* \< .05), while the remaining variables were not significant ([Fig. 2](#f0010){ref-type="fig"} ).Fig. 1Flow chart of the study.Fig. 1Table 1General demographic information.Table 1General informationPositive groupNegative group*Pn* = 54*n* = 76Gender0.15 Male, n(%)28(51.9%)49(64.5%) Female, n(%)26(48.1%)27(35.5%)Age, years45.1 ± 13.441.8 ± 13.60.18Symptoms onset to the first visit, day(s)4.0(1.0--6.0)3.0(1.0--5.0)0.55Exposure to symptoms onset, day(s)6.0(3.5--9.5)5.0(3.0--10.0)0.90Epidemiological history Patients with Wuhan residence history, n(%)20(37.0%)8(10.5%)\<0.01 Patients with Wuhan travel history, n(%)19(35.2%)22(28.9%)0.45Exposure of South China Seafood Market, n(%)2(3.7%)0(0%)0.17Contact with patients of fever or COVID-19, n(%)25(46.3%)27(35.5%)0.22Clustering occurrence, n(%)24(44.4%)8(10.5%)\<0.01History of hypertension, n(%)7(13.0%)10(13.2%)0.97History of diabetes, n(%)3(5.6%)5(6.6%)1.00History of cardiovascular disease, n(%)1(1.9%)2(2.6%)1.00History of cerebrovascular disease, n(%)1(1.9%)0(0%)0.42History of chronic liver disease, n(%)0(0%)3(3.9%)0.27History of chronic kidney disease, n(%)0(0%)0(0%)--History of cancer, n(%)0(0%)1(1.3%)1.00Smoking, n(%)11(20.4%)17(22.4%)0.79Drinking, n(%)8(14.8%)15(19.7%)0.47[^2]Fig. 2Various combinations of GGO on early CT imagingGGO, ground glass opacityVarious combinations of GGO on early CT imaging were shown as above. A, B, C: GGO with bilateral and subpleural distribution; D: GGO with air bronchogram and bilateral lower pulmonary distribution; E: GGO with air bronchogram; F: GGO with crazy-paving pattern and bilateral lower pulmonary distribution.Fig. 2

3.2. Comparisons of single CT imaging features {#s0045}
----------------------------------------------

The characteristics of the lesion morphologies are shown in [Table 2](#t0010){ref-type="table"} . The positive group patients in the early stage mostly had GGOs (38, 70.4%), a typical imaging manifestation in viral pneumonia, followed by the crazy-paving pattern (16, 29.6%), air bronchogram (14, 25.9%), consolidation (12, 22.2%) and pleural thickening (11, 20.4%). Pulmonary nodules, pleural effusion, lymphadenopathy and pulmonary atelectasis were rare. The presence of GGOs, the crazy-paving pattern, air bronchogram, and pleural thickening was significantly different between the two groups (*P* \< .05). The remaining variables were not (*P* \> .05).Table 2Lesion morphology in chest CT.Table 2Morphological characteristicsPositive groupNegative group*P*n = 54n = 76GGO38(70.4%)32(42.1%)0.01Consolidation12(22.2%)29(38.2%)0.05Crazy-paving pattern16(29.6%)3(3.9%)\<0.01Air bronchogram14(25.9%)5(6.6%)\<0.01Cavitation1(1.9%)1(1.3%)1.00Pulmonary nodule8(14.8%)15(19.7%)0.47Lymphadenopathy4(7.4%)0(0%)0.03Pleural effusion0(0%)4(5.3%)0.14Pulmonary atelectasis1(1.9%)2(2.6%)1.00Pleural thickening11(20.4%)4(5.3%)\<0.01[^3]

The lesion distribution characteristics are shown in [Table 3](#t0015){ref-type="table"} . For the positive group, lesions in the early stage were mainly distributed bilaterally (40, 74.1%) and near the pleura (33, 61.1%). The involvement of two lobes and all lobes were most common, seen in 18 (33.3%) and 13 patients (24.1%), respectively. Forty-five patients (83.3%) showed involvement of at least two lobes. Left lower lobe (40, 74.1%) and right lower lobe (43, 79.6%) involvement were also frequently observed. Peripheral, bilateral or lower lung distribution and multilobe involvement was significantly different between the two groups (*P* \< .05), and the remaining variables were not significant (*P* \> .05).Table 3Lesion distribution in chest CT.Table 3Distribution characteristicsPositive groupNegative group*P*n = 54n = 76Bilateral pulmonary distribution40(74.1%)30(40.8%)\<0.01Bilateral lower pulmonary distribution32(59.3%)19(25.0%)\<0.01Peripleural distribution33(61.1%)21(27.6%)\<0.01Distribution of lung lobes Right upper lobe26(48.1%)27(35.5%)0.15 Right middle lobe22(40.7%)23(30.3%)0.22 Right lower lobe43(79.6%)35(46.1%)\<0.01 Left upper lobe28(51.9%)31(40.8%)0.21 Left lower lobe40(74.1%)37(48.7%)\<0.01Number of affected lobes\<0.01 Patients of 1 affected lobe9(16.7%)37(48.7%) Patients of 2 affected lobes18(33.3%)15(19.7%) Patients of 3 affected lobes7(13.0%)13(17.1%) Patients of 4 affected lobes7(13.0%)1(1.3%) Patients of 5 affected lobes13(24.1%)10(13.2%) Patients of \>2 affected lobes45(83.3%)39(51.3%)\<0.01

3.3. Comparisons of combined early CT imaging features {#s0050}
------------------------------------------------------

According to the statistical results in [Table 2](#t0010){ref-type="table"}, [Table 3](#t0015){ref-type="table"}, we found that GGOs were the basic manifestation in the positive group. To increase distinguishability on imaging, we combined GGOs with other statistically significant features. [Table 4](#t0020){ref-type="table"} shows the various combinations of imaging features on early CT. When two features were combined, the combination of GGOs with bilateral pulmonary distribution and the combination of GGOs with pleural distribution were the most common, found in 31 (57.4%) and 30 patients (55.6%), respectively. When three items were combined, 26 patients (48.1%) presented with GGOs and bilateral pulmonary and peripleural distributions. When four items were combined, the combination of GGOs, a bilateral pulmonary distribution, the crazy-paving pattern, and pleural distribution was the most common, seen 12 patients (22.2%). The presence of almost all these combinations was significantly different between the two groups (*P* \< .05), except for the combination of GGOs with consolidation.Table 4Combined CT imaging features between positive group and negative group.Table 4Combined featuresPositive groupNegative group*P*n = 54n = 76GGO + Consolidation11(20.4%)8(10.5%)0.12GGO+ Crazy-paving pattern16(29.6%)3(3.9%)\<0.01GGO + Air bronchogram14(15.9%)4(5.3%)\<0.01GGO + Bilateral pulmonary distribution31(57.4%)15(19.7%)\<0.01GGO + Bilateral lower pulmonary distribution21(38.9%)8(10.5%)\<0.01GGO + Peripleural distribution30(55.6%)16(21.1%)\<0.01GGO + Bilateral lower pulmonary distribution+Peripleural distribution17(31.5%)5(6.6%)\<0.01GGO + Bilateral pulmonary distribution+Peripleural distribution26(48.1%)8(10.5%)\<0.01GGO + Crazy-paving pattern+Peripleural distribution12(22.2%)3(3.9%)\<0.01GGO + Air bronchogram +Peripleural distribution11(20.4%)2(2.6%)\<0.01GGO + Crazy-paving pattern+Bilateral lower pulmonary distribution11(20.4%)1(1.3%)\<0.01GGO + Air bronchogram+Bilateral lower pulmonary distribution8(14.8%)1(1.3%)\<0.01GGO + Bilateral pulmonary distribution+Crazy-paving Pattern+ Pleural distribution12(22.2%)2(2.6%)\<0.01GGO + bilateral pulmonary distribution+Air bronchogram+ Peripleural distribution10(18.5%)1(1.3%)\<0.01GGO + Bilateral lower pulmonary distribution+Crazy-paving pattern+Peripleural distribution9(16.7%)1(1.3%)\<0.01GGO + Bilateral lower pulmonary distribution+Air bronchogram +Peripleural distribution6(11.1%)1(1.3%)0.02[^4]

3.4. Comparisons of the diagnostic value of combined imaging features between the positive and negative groups {#s0055}
--------------------------------------------------------------------------------------------------------------

As shown in [Table 5](#t0025){ref-type="table"} , GGOs with bilateral pulmonary distribution and GGOs with peripleural distribution both presented the highest sensitivity of 57%, followed by GGOs combined with bilateral pulmonary distribution and peripleural distribution at 48%. The remaining combinations had sensitivities of approximately 25%. In contrast, these combinations presented with much better specificity. When combining two items, the specificity of GGOs with the crazy-paving pattern was up to 96%, followed by GGOs with air bronchogram (95%). When three features were combined, the specificity was over 95%, and GGOs with the crazy-paving pattern and bilateral pulmonary distribution had the highest at 99%. The specificity of diagnosis was almost 99% for four items.Table 5The diagnostic value of combined CT imaging features between positive group and negative group.Table 5Combined featuresSensitivitySpecificityGGO+ Crazy-paving pattern0.300.96GGO + Air bronchogram0.260.95GGO + Bilateral pulmonary distribution0.570.81GGO + Bilateral lower pulmonary distribution0.390.89GGO + Peripleural distribution0.570.79GGO + Bilateral lower pulmonary distribution+Peripleural distribution0.310.93GGO + Bilateral pulmonary distribution+Peripleural distribution0.480.89GGO + Crazy-paving pattern+Peripleural distribution0.220.96GGO + Air bronchogram +Peripleural distribution0.200.97GGO + Crazy-paving pattern+Bilateral lower pulmonary distribution0.200.99GGO + Air bronchogram+Bilateral lower pulmonary distribution0.150.99GGO + Bilateral pulmonary distribution+Crazy-paving Pattern+ Peripleural distribution0.220.97GGO + bilateral pulmonary distribution+Air bronchogram+ Peripleural distribution0.190.99GGO + Bilateral lower pulmonary distribution+Crazy-paving pattern+Peripleural distribution0.170.99GGO + Bilateral lower pulmonary distribution+Air bronchogram +Peripleural distribution0.110.99[^5]

4. Discussion {#s0060}
=============

In the positive group, our study showed that GGOs are the basic manifestation in CT imaging of COVID-19, followed by consolidation, the crazy-paving pattern and air bronchogram. Lesions were mainly distributed bilaterally, close to the lower lungs or the pleura. These findings are similar to those in previous descriptive studies on COVID-19 \[[@bb0040],[@bb0050],[@bb0065],[@bb0070]\] and also overlap with the imaging features of other viral pneumonias. For this reason, we estimated the pathological mechanism of COVID-19 involves transmission though the respiratory tract and damage to the terminal bronchioles and lung parenchyma near the bronchioles in the early stages, which in turn affect the entirety of the lung lobules and results in diffuse alveolar damage, similar to other viral pneumonias \[[@bb0075]\]. Apparently, the imaging features of COVID-19 greatly resemble those of SARS (severe acute respiratory syndrome) and MERS (Middle East respiratory syndrome), which are other members of the coronavirus family \[[@bb0080], [@bb0085], [@bb0090], [@bb0095]\].

However, some distinguishable imaging features can be seen for COVID-19. The CT imaging features of SARS are mainly manifested by GGOs with consolidation \[[@bb0100]\]. Lower lung distribution and peripheral involvement are more common, and there is more unifocal involvement than multifocal and bilateral involvement. The manifestations of MERS on chest CT are mainly subpleural distributions, accompanied by extensive GGOs and consolidations \[[@bb0080]\]. In addition, influenza virus pneumonia has a high frequency of occurrence in winter and spring, with manifestations of cavities, GGOs and a lobular distribution on chest CT \[[@bb0060]\].

Furthermore, we found that GGOs, the crazy-paving pattern, air bronchogram, and pleural thickening were more common in patients with COVID-19 than in patients with other viral pneumonias on chest CT imaging. Peripheral, bilateral or lower lung distribution and multilobe involvement also presented more frequently in COVID-19 patients. This may help us identify COVID-19 patients with chest CT scans. Previous studies have to date merely described the dynamic changes in the chest CT imaging of COVID-19 and presented the features currently used in the diagnosis of the disease \[[@bb0040],[@bb0050],[@bb0065],[@bb0070],[@bb0105]\]. Some of them focused on the sensitivity compared to that of RT-PCR with a relatively small sample size, but they did not compare these features with those of other viral pneumonias or explain how a differential diagnosis could be made by chest CT \[[@bb0045],[@bb0055]\]. Our study includes all suspected cases, including positive and negative cases, which may be more useful for early differential diagnosis.

Theoretically, a definite diagnosis cannot be achieved on the basis of one single imaging feature, as it may overlap with individual imaging features from other viral pneumonias as mentioned above. Therefore, we combined several statistically significant imaging features to evaluate the diagnostic value of chest CT scans. Apparently, the combination of features resulted in relatively low sensitivity but extremely high specificity. The average specificity of all combinations was approximately 90%, and the combination of GGOs with the crazy-paving pattern and bilateral pulmonary distribution showed the highest specificity at 99% when three items were combined. The use of a four-item combination also resulted in 99% specificity. In conclusion, the combinations of GGO with different features from chest CT might significantly increase the specificity in the diagnosis of COVID-19. This means that in a series presenting crazy-paving patterns, air bronchograms, bilateral lower pulmonary distributions, bilateral pulmonary distributions and pleural distributions, as long as they appear simultaneously with GGOs on chest CT, COVID-19 should be highly suspected, even if the patient has repeated negative RT-PCR outcomes. This might help emergency physicians identify COVID-19 patients faster and more effectively. Based on accumulated experience, we recommend that these patients be quarantined and have their RT-PCR tests repeated until the average incubation ends, especially in areas with severe outbreaks. Epidemiological exposure, RT-PCR tests and chest CT scans are equally critical to diagnosis.

There are several limitations in our study. First, the goal was to compare the difference in CT imaging features between confirmed and nonconfirmed COVID-19 patients. Some early lesions might not be visible on chest CT since the maximum incubation period is 14 days or even more \[[@bb0030]\]. Therefore, the expression of time may not be precise enough according to the development of this disease. Second, the current gold standard for the diagnosis of COVID-19 is merely the RT-PCR test \[[@bb0030]\]. Since the test samples are mostly pharynx swabs rather than bronchoalveolar lavage fluid (BALF) samples, false negative results might still be present after repeat testing.

In summary, the manifestations of COVID-19 vary. Some patients show similar manifestations with those of common viral pneumonias. However, COVID-19 still demonstrates specific imaging characteristics. The combinations with GGOs could be useful in the identification and differential diagnosis of COVID-19, alerting clinicians to isolate patients for prompt treatment and repeat RT-PCR tests until the incubation period ends.
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